Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

Local authorities are facing unprecedented challenges over the medium term, including those relating to austerity…

Former cabinet minister Hazel Blears MP will join the InformationDaily.TV AnswerTime® live studio debate…

The radio programme ‘Does he take sugar?’ highlighted a tendency to treat disabled people as generally…

In the future you won’t necessarily own a car but might summon a driverless car whenever you need one. We…

Derek Brown, transactions manager at Northumberland County Council, discusses how councils can more effectively…

Jason Ward, UKI North, Scotland Ireland Director at EMC, discusses a new Big Data League report and how the public…

Interest rates will rise before long, but are unlikely to go back to levels once considered normal, says the former…

As the Conservative-Labour hold on power continues to weaken, suppliers need to get their views across to a wider…

Do you do digital? Take the test

The Information Daily is collaborating with Socitm to research organisations' commitment to and capability for a digital future.

Take the test

View Results

If you have already taken the test, you may view the latest detailed results by entering your email address below


Headline results so far: Results from 111 users

Corporate commitment: 46%
0%
100%
50%
Digital capability: 52%
0%
100%
50%

When I was 31 I went to see my GP about a mole on my right leg. The GP looked at it, mumbled something about not…

Knowsley's chief executive leaves to save money, Croydon reckons devolution could bring £5bn into local economy…

The political parties are stacked in a holding pattern over the issue of UK airport expansion. A hung parliament…

Many of the structures which underpin the NHS are broken. The world has changed, the demands of patient care have…